Find a Study

STUDY SEARCH RESULTS
  Notify Me When Search is Updated

1 study found for your search request:  3475-158

Study of Pembrolizumab (MK-3475) in Participants with Advanced Solid Tumors (MK-3475-158/KEYNOTE-158...
Condition: advanced cancer, anal carcinoma, anal cancer, biliary cancer, cholangiocarcinoma, bile duct cancer, neuroendocrine tumor, carcinoid tumor, endometrial carcinoma, endometrial cancer, cervical carcinoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: Both
Study ID: NCT02628067
Status: Recruiting
Has Enrolling Locations in US or Canada



Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site

Accessibility icon